Indian drugmaker Biocon, looking to grab a piece of the exploding weight-loss drug market as earl...
Biocon is currently trading at Rs. 270.20, up by 7.10 points or 2.70% from its previous closing o...
Biocon is currently trading at Rs. 260.55, up by 3.95 points or 1.54% from its previous closing o...
Biopharmaceutical company Biocon's unit Biocon Biologics will sell its Indian branded formula...
Indian biopharmaceutical company Biocon Ltd swung to a third-quarter profit on Thursday, bo...
Biocon Ltd Buy Biocon Ltd @282-283; Target 288.00; Stop Loss 3734.00 &nb...
Hindustan Unilever Ltd Buy Hindustan Unilever Ltd @2651-2653; Target 2679.0...
Enhanced efforts needed to improve biosimilars outlook * Biocon (BIOS) has delivered 22%/25% r...
BIOS’ 2Q earnings was below JMFe. Generics performance was lower due to API pricing pressur...
Karnataka Minister for Information Technology and Biotechnology, Priyank Kharge, said that the th...
Indian biopharmaceutical company Biocon reported a smaller-than-expected quarterly profit on Frid...
Indian pharmaceutical giant Biocon on Friday reported a net profit of Rs 172.7 crore in the Septe...
An analysis for the month of November indicated that the Nifty had closed in the green on five oc...
Kedar Upadhye has been appointed as the new Chief Financial Officer (CFO) of Biocon Biologics whi...
BIOS? implied hold co discount is now >40% - this makes the risk-reward extremely favourable....
Indian drugmaker Biocon Ltd on Monday appointed Peter Bains as the group's chief executive office...